Home | Welcome to Contract Pharma   
Last Updated Friday, December 19 2014

Print

Trials & Filings in Brief: Oct. 10, 2013



By Gil Roth



Published October 10, 2013
Related Searches: www.contractpharma.com Phase II Phase III contractpharma
Preclinical
Galectin posts fibrosis . . . read more

Medivir selects neuropathic pain candidate . . . read more

Phase II
Pergamum peptide posts positive results . . . read more

Phase III
Gilead Cuts CLL Study Short After Positive Results  . . . read more

Lundbeck, Otsuka start Alzheimer's trials . . . read more

Relypsa posts positive results for patiromer . . . read more

Filings
Alkermes MDD drug gets fast-track status . . . read more

Chelsea NOH treatment to get advisory review . . . read more

Cirrus receives FDA grant for MDI research . . . read more


blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On